Dalton Venture is a fund management company established in 2015 and based in Shanghai, China. It focuses on early-stage investments in the healthcare sector, particularly in medical services, biotechnology, and healthcare technology. Additionally, Dalton Venture engages in industrial mergers and acquisitions within the big health domain, aiming to foster innovation and growth in this critical field.
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
Astribot
Series A in 2025
Astribot is a developer of consumer humanoid robots and integrated bionic robots.
Yuetong Eye Clinic
Series A in 2024
Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Xiwei Biotechnology
Series A in 2024
Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.
Macrolux Medical
Series B in 2024
MacroLux is a medical technology company that specializes in endoscopic interventional solutions for diagnosis and treatment. The company focuses on developing devices that enhance the detection and treatment of conditions in urology, respiratory, and digestive health. By offering advanced endoscopic therapies, MacroLux aims to improve patient outcomes through earlier diagnosis and more effective treatment options, catering to a wide range of medical customers.
PharMolix
Seed Round in 2024
PharMolix Inc. is an AI & Biotechnology company that aims to revolutionize the biomedical industry with multi-modal AI foundation models.
Mol Breeding
Series B in 2024
Molbreeding is a biotechnology company specializing in molecular breeding technology for both animals and plants. It offers advanced genotyping solutions aimed at enhancing breeding processes. The firm emphasizes research and development in this field, utilizing proprietary technologies such as GenoPlexs and GenoBaits. These innovations provide customers with high capture efficiency, extensive coverage, and adaptable sample options, all while maintaining cost-effective custom services. Molbreeding's focus on molecular breeding positions it as a key player in the advancement of agricultural biotechnology.
Aiyisheng
Angel Round in 2024
Aiyisheng is a food manufacturing business that focuses on the creation, development, manufacturing, and marketing of nutritious foods. Aiyisheng offers a range of health foods including vitamins, minerals, dietary supplements, and others. It provides consumers with healthy food products with its professional R&D capabilities.
Jichen Biotechnology
Seed Round in 2024
Jichen Biotechnology designs, manufactures, supplies, and maintains automation and information equipment systems.
Oushisheng Technology
Series B in 2024
Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world.
Sino-Biocan
Series B in 2024
Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.
Macrolux Medical
Series A in 2024
MacroLux is a medical technology company that specializes in endoscopic interventional solutions for diagnosis and treatment. The company focuses on developing devices that enhance the detection and treatment of conditions in urology, respiratory, and digestive health. By offering advanced endoscopic therapies, MacroLux aims to improve patient outcomes through earlier diagnosis and more effective treatment options, catering to a wide range of medical customers.
Bingjing Smart
Seed Round in 2024
Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascular interventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
Rhino Medical
Series A in 2023
Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
Jingqin Intelligent Manufacturing
Angel Round in 2023
Jingqin Intelligent Manufacturing is an innovative technology company that specializes in developing surgical instruments in the medical field.
HC Scientific
Series B in 2023
HC Scientific (Chengdu) L.L.C., founded in early 2016, focuses on developing intelligent solutions within the life sciences sector. The company aims to be a trusted partner for global clients by offering innovative products, including genetic testing instruments, reagents, and software. These products are primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is recognized as a national high-tech enterprise, emphasizing autonomous research and the development of intellectual property. The company participates in significant national and provincial scientific initiatives and is supported by a team of experts, including returning PhDs. Its product offerings streamline complex tasks for life science practitioners, delivering high-throughput, automated, and cost-effective genetic testing solutions while creating value for collaborative partners.
FUE Bioscience
Series A in 2023
FUE Bioscience is a medical robot R&D business that specializes in microsurgery above the head and neck. It continues to develop a product matrix of fully intelligent, high-precision, and anthropomorphic surgical robots based on the platform of macro-micro-controlled humanoid dual-arm robots.
Mol Breeding
Series A in 2023
Molbreeding is a biotechnology company specializing in molecular breeding technology for both animals and plants. It offers advanced genotyping solutions aimed at enhancing breeding processes. The firm emphasizes research and development in this field, utilizing proprietary technologies such as GenoPlexs and GenoBaits. These innovations provide customers with high capture efficiency, extensive coverage, and adaptable sample options, all while maintaining cost-effective custom services. Molbreeding's focus on molecular breeding positions it as a key player in the advancement of agricultural biotechnology.
Bingjing Smart
Seed Round in 2023
Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascular interventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
Shanhai Semiconductor
Series A in 2023
Shanhai Semiconductor is a high-performance digital-analog hybrid and signal chain chip developer.
Borch Biotech
Angel Round in 2023
Borch Biotech is committed to the R&D and scientific research transformation of biological tissue membranes and derivative medical devices.
Yisuo Intelligent
Angel Round in 2023
Yisuo Intelligent is a scientific research and production start-up company dedicated to new pharmaceutical packaging technology and intelligent drug delivery systems. Their products include pharmaceutical material precision devices, targeted drug delivery devices, and precision intelligent systems to serve the pharmaceutical industry.
Macrolux Medical
Series A in 2023
MacroLux is a medical technology company that specializes in endoscopic interventional solutions for diagnosis and treatment. The company focuses on developing devices that enhance the detection and treatment of conditions in urology, respiratory, and digestive health. By offering advanced endoscopic therapies, MacroLux aims to improve patient outcomes through earlier diagnosis and more effective treatment options, catering to a wide range of medical customers.
NowYonMedical
Venture Round in 2023
NowYonMedical specializes in the production of medical device products. It also offers technical consulting, health management, and technology research in the field of life sciences.
Eartech
Seed Round in 2022
Eartech specializes in developing intelligent audiometry and hearing aid technology. The company focuses on enhancing hearing capabilities by utilizing advanced chip and voice recognition technology to process, classify, and clarify sounds. Through its innovative approach, Eartech aims to improve hearing testing and rehabilitation services for individuals with hearing impairments, contributing to the advancement of the hearing aid industry.
Juventas
Series C in 2021
Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.
Triastek
Series B in 2021
Triastek specializes in the development of 3D printed medicines and the associated manufacturing facilities. The company is focused on innovating pharmaceutical 3D printing technology to enhance the design, development, and production of pharmaceutical products. Triastek has created proprietary technology that encompasses the entire process, from pharmaceutical dosage form design to digital development and continuous production. This approach aims to revolutionize drug delivery and manufacturing solutions within the medical industry. Additionally, Triastek has filed patent applications to protect its technological advancements.
Forerunner Medical
Series B in 2021
Forerunner Medical (Shanghai) Co., Ltd., established in 2009, specializes in the development and manufacturing of medical devices tailored for minimally invasive procedures. The company focuses on low-temperature plasma radio-frequency generators and electrodes, catering to sports medicine and tumor treatment. By leveraging domestic clinical data and technology from the United States, Forerunner Medical aims to meet both local and global healthcare needs. Their commitment to quality and safety is evident in their products, which are designed to offer enhanced performance, aesthetic appeal, and user convenience. With a strong emphasis on innovation and professional expertise, Forerunner Medical strives to provide superior medical technologies that improve surgical outcomes for doctors and patients alike.
Triastek
Series A in 2020
Triastek specializes in the development of 3D printed medicines and the associated manufacturing facilities. The company is focused on innovating pharmaceutical 3D printing technology to enhance the design, development, and production of pharmaceutical products. Triastek has created proprietary technology that encompasses the entire process, from pharmaceutical dosage form design to digital development and continuous production. This approach aims to revolutionize drug delivery and manufacturing solutions within the medical industry. Additionally, Triastek has filed patent applications to protect its technological advancements.
Noah Healthcare
Series A in 2019
Noah Healthcare is a private healthcare provider based in Guangzhou, China, specializing in services for women and children. The organization focuses on pediatrics, obstetrics, and gynecology, offering a range of medical services tailored to children aged 0 to 18, including treatment for common illnesses, health examinations, growth assessments, and vaccinations. For female patients, Noah Healthcare provides comprehensive care that includes pregnancy preparation, pre-pregnancy examinations, maternal healthcare, post-natal support, and dysplasia screening. Notably, it was the first to establish a professional ultrasound center in Guangdong Province and features a core medical team comprised of renowned experts from reputed institutions, ensuring high-quality, internationally recognized healthcare services.
Juventas
Series A in 2019
Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.
Wellem
Series C in 2019
Wellem is an operator of pediatric clinic franchise. United Wellness Pediatric Gubei Clinic (Wellem) is a private clinic that provides care for babies, children, and young adults. They believe in leveraging competition and innovation to create better care, and base their service on the American service standard. They offer general pediatrics, pediatric dental care, specialized childcare, and imported vaccines. And can help children with any issue from physical growth, to nutrition, and language to vision, and even academic skills. Parents can also bring their children for preventative check ups, with little waiting time and simple registration.
NeighBor Doc
Series A in 2018
Neighbor Doc is an online platform that delivers a range of healthcare services, aiming to enhance community medical offerings. The organization combines general and specialty care, integrating both online and offline medical services. Its focus includes providing on-demand healthcare solutions such as complicated surgery, pediatrics, dental care, and gynecology. Neighbor Doc is committed to establishing a comprehensive community healthcare network that emphasizes affordability, quality, and convenience, thereby improving the overall capabilities of local medical services.
Orange Dental
Series A in 2018
Orange Dental operates a dental clinic that specializes in providing general dental care for children. The clinic is uniquely designed with a theme park ambiance to create a comforting environment for young patients, aiming to alleviate anxiety associated with dental visits. This thoughtful approach helps ensure that children have a more positive experience while receiving necessary dental treatments, allowing parents to select a tailored service that prioritizes their children's comfort and well-being.
Wellem
Series B in 2018
Wellem is an operator of pediatric clinic franchise. United Wellness Pediatric Gubei Clinic (Wellem) is a private clinic that provides care for babies, children, and young adults. They believe in leveraging competition and innovation to create better care, and base their service on the American service standard. They offer general pediatrics, pediatric dental care, specialized childcare, and imported vaccines. And can help children with any issue from physical growth, to nutrition, and language to vision, and even academic skills. Parents can also bring their children for preventative check ups, with little waiting time and simple registration.
DeepWise
Series B in 2018
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.
Orange Dental
Series A in 2018
Orange Dental operates a dental clinic that specializes in providing general dental care for children. The clinic is uniquely designed with a theme park ambiance to create a comforting environment for young patients, aiming to alleviate anxiety associated with dental visits. This thoughtful approach helps ensure that children have a more positive experience while receiving necessary dental treatments, allowing parents to select a tailored service that prioritizes their children's comfort and well-being.
DeepWise
Series A in 2017
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.
Landing Medical High Technology
Series B in 2017
Landing Shares is an AI-driven med-tech firm that develops artificial intelligence cervical cancer screening diagnostic technology.
Wellem
Series A in 2017
Wellem is an operator of pediatric clinic franchise. United Wellness Pediatric Gubei Clinic (Wellem) is a private clinic that provides care for babies, children, and young adults. They believe in leveraging competition and innovation to create better care, and base their service on the American service standard. They offer general pediatrics, pediatric dental care, specialized childcare, and imported vaccines. And can help children with any issue from physical growth, to nutrition, and language to vision, and even academic skills. Parents can also bring their children for preventative check ups, with little waiting time and simple registration.
xinws.com
Series A in 2016
xinws.com provides heart monitoring services to help their users discover every abnormal heart rhythm. The users can also learn about their heart health anytime and anywhere. They also offer programmes to help their users lose weight scientifically, lower blood sugar, blood lipids, blood pressure, and uric acid to reduce taking drugs to protect their heart health.
Yishengzhan
Series A in 2015
Yishengzhan is an online medical education community for doctors based in China.
Baisi Bude Jie
Series B in 2015
Baisi Bude Jie is a short piece of video entertainment community service provider.
Yixue Jie
Series A in 2014
Yixue Jie is an app that offers medical information to medical workers. They provide information in these categories such as grassroots medical voice in the medical field, medical tumor channel, medical rheumatology and immunity channel, medical skin channel, medical cardiovascular channel, medical endocrinology channel, medical neurology channel, medical blood channel, medical pediatric channel, medical obstetrics and gynecology channel, medical respiratory channel, medical nephrology channel, digestive liver disease channel in medical circles, clinical pharmacy channel of the medical community, medical rare disease channel, medical cancer association, medical emergency and critical care channel, medical spirit channel, medical surgical channel, medical nursing channel, medical ophthalmology channel, medical infection channel, medical anesthesia channel, medical orthopedics channel, medical testing channel, medical image diagnosis and intervention channel, medical pathology channel, clinical decision assistant, a course in the medical field, and medical examination. It helps clinicians in clinical decision-making and professional advancement.
xinws.com
Angel Round in 2014
xinws.com provides heart monitoring services to help their users discover every abnormal heart rhythm. The users can also learn about their heart health anytime and anywhere. They also offer programmes to help their users lose weight scientifically, lower blood sugar, blood lipids, blood pressure, and uric acid to reduce taking drugs to protect their heart health.
Aiyisheng
Aiyisheng is a food manufacturing business that focuses on the creation, development, manufacturing, and marketing of nutritious foods. Aiyisheng offers a range of health foods including vitamins, minerals, dietary supplements, and others. It provides consumers with healthy food products with its professional R&D capabilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.